CDKN2A and lung adenocarcinoma: For instance, migration and invasion in lung adenocarcinoma cells can be substantially inhibited through the blockage of the complex LIMK1/PAK4/cofilin42, and methylation changes of CDKN2A may interact with HRAS to regulate the activity of MAPK1 in lung adenocarcinoma43.